Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S10 pseudogene 30 (RPS10P30) is a **processed pseudogene**—a DNA sequence similar to the functional RPS10 gene but does not encode a functional protein. It arises from the genomic duplication or retrotransposition of the *RPS10* transcript and is located on chromosome 22q11.23[8]. Pseudogenes like RPS10P30 are common in the human genome and typically do not exhibit biological function, regulatory activity, or direct links to human disease. Their presence is often cataloged in genomic studies, but they are generally not relevant as drug targets, biomarkers, or therapeutic receptors[1][5][8][11]. Summary of Key Points: - RPS10P30 is a non-coding pseudogene, not a functional gene[1][5][8]. - It has no established therapeutic, diagnostic, or pharmacological role. - It is not involved in any biological pathway, mechanism of drug action, or disease process. - Any reference to it as a drug target or as playing a biological role would be incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S10 pseudogene 30 (RPS10P30).